Lv21
156 积分 2023-09-27 加入
Navigating Treatment Pathways in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies
4小时前
已完结
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
7小时前
已完结
Development of new techniques and clinical applications of liquid biopsy in lung cancer management
1个月前
已完结
Individualized tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of non-small cell lung cancer (NSCLC) - the MEDAL study
1个月前
已完结
Genomic profiling of aggressive pathologic features in lung adenocarcinoma
1个月前
已完结
Incorporation of a Molecular Prognostic Classifier Improves Conventional Non–Small Cell Lung Cancer Staging
1个月前
已完结
A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
1个月前
已完结
The rediscovery of platinum-based cancer therapy
1个月前
已完结
Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes
2个月前
已完结
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
2个月前
已完结
皖公网安备34019202002308
